|
names
|
- (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
- (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
- (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3,4-diol
- (2S,3S,4R,5S)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
- 9-beta-D-Ribofuranosyl-9H-purin-6-amine
- AC-27494
- Adenosine
- Adenosine, >=99%
- Adenosine (Adenocard)
- Adenosine, BioReagent, suitable for cell culture
- Adenosine, European Pharmacopoeia (EP) Reference Standard
- Adenosine, Pharmaceutical Secondary Standard; Certified Reference Material
- Adenosine (Standard)
- Adenosine, United States Pharmacopeia (USP) Reference Standard
- Adenosine, Vetec(TM) reagent grade, 98%
- Alpha-adenosine
- Formycin A, from Streptomyces kaniharaensis, >=98% (HPLC)
- L-Adenosine
- Vidarabine
|